desloratadine, are currently marketed.

Approved prodrugs

Approximately 10% of all marketed drugs worldwide can be considered prodrugs. Since 2008, at least 30 prodrugs have been approved by the FDA. Seven prodrugs were approved in 2015 and six in 2017. Examples of later approved prodrugs are dabigatran etexilate (approved in 2010), gabapentin enacarbil (2011), sofosbuvir

1.Previous
3.Next